The Young Health Programme is AstraZeneca’s global community investment initiative.

It has a unique focus on young people and primary prevention of the most common non-communicable diseases (NCDs), such as type 2 diabetes, cancer, heart and respiratory disease. Today, more than 38 million people die from NCDs each year. NCDs have become the number one cause of death and illness and what the World Health Organization calls an "invisible epidemic."

Why focus on adolescents?

Scientific research has shown that the risk behaviours such as tobacco use, alcohol abuse and unhealthy eating that can lead to NCDs in later life are often formed during adolescence and, once started, are hard to change. In fact, 70% of premature deaths in adults can be attributed to behaviours started in adolescence.

Today, young people make up more than 25% of the global population and in some countries, they make up over 50% of the national population. If we can help young people establish the right habits now, when they are young, we have the opportunity to help them become healthier as adults.

What are NCDs?

Non-communicable diseases, (NCDs) also known as chronic diseases, are not passed from person to person. They are of long duration and generally slow progression.

The AstraZeneca Young Health Programme uses a unique approach

The Young Health Programme works with many expert organisations and combines on the ground programmes, research and evidence generation, and advocacy, to target the risk behaviours that can lead to common NCDs in adulthood. At the core of our work is a commitment to ensure young people are engaged and have a voice in identifying their health needs as well as planning and delivering solutions.

  • Programmes

    Working on-the-ground to tailor prevention programmes to community needs

  • Research

    Filling the gaps in evidence to support a call for prevention programming

  • Advocacy

    Working globally and locally to put adolescent health on the policy agenda

Find helpful resources